• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchEQRx
    Picture of EQRx logo

    EQRX — EQRx News Story

    $2.340.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid Cap
    • Market Cap
      $1.14bn
    • Enterprise Value
      -$71.09m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • EQRX Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    EQRX Dividends
    All News

    NASDAQ RESUMED AT 07:30 AM

    Picture of EQRx logoEQRx
    06/08/2021 12:30
    NASDAQ RESUMED  CMLTU.O  AT 07:30 AM
    

    Recent news on EQRx

    See all news
    • Brief: Leading Independent Proxy Advisory Firms ISS And Glass Lewis Recommend Revolution Medicines Stockholders Vote "FOR" Proposed Acquisition Of EQRx, Inc

      01/11/2023 11:27
    • Brief: Revolution Medicines Inc Says Will Acquire EQRx In An All-Stock Transaction

      01/08/2023 12:13
    • U.S. RESEARCH ROUNDUP- Cigna Group, McKesson, Zscaler

      09/05/2023 08:21
    • Brief: EQRx posts Q1 EPS USD -0.17

      08/05/2023 21:05
    • Brief: EQRx Says Jami Rubin Will Step Down As Chief Financial Officer

      13/03/2023 13:42

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.